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S U M M A R Y
Objectives: To investigate the association between Klebsiella pneumoniae-mediated invasive syndrome
and underlying diseases in patients and/or K. pneumoniae characteristics, including the rmpA, rmpA2, and
magA genes, capsular polysaccharide (cps) K1 or K2 serotypes, hypermucoviscosity (HV) phenotype, and
extended-spectrum b-lactamase (ESBL) production.
Methods: This was a prospective cross-sectional study.
Results: The invasive syndrome was detected in 19 of 91 patients (20.9%) with K. pneumoniae infections,
and diabetes mellitus was themost common underlying disease (9 of 19). The presence of rmpA or rmpA2
was found in 91.4% of the 35 isolates with the HV phenotype, while in only 17.9% of the 56 isolates
without HV phenotype. Multivariate logistic regression analysis showed that the HV phenotype was an
independent risk factor for K. pneumoniae-mediated invasive syndrome (odds ratio (OR) 58.24, 95%
conﬁdence interval (CI) 7.23–468.87; p< 0.001) andwas negatively associatedwith ESBL production (OR
0.042, 95% CI 0.005–0.331; p = 0.003). Binary logistic regression analysis revealed that the invasive
syndrome was not inﬂuenced by the presence of diabetes mellitus among patients infected with K.
pneumoniae positive for the rmpA or rmpA2 gene, HV phenotype, or cps K1/K2 serotype.
Conclusions: The HV phenotype of K. pneumoniae contributes to invasive syndrome and is a negative
predictor for K. pneumoniae acquisition of ESBLs.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Over the past two decades, Klebsiella pneumoniae has become a
signiﬁcant cause of primary pyogenic liver abscess.1–5 In addition
to liver abscess, patients infected with K. pneumoniaemay develop
a potentially fatal condition—distinctive invasive syndrome (also
called ‘septic metastasis’).2 With regard to risk factors for
distinctive invasive syndrome caused by K. pneumoniae, it has
been suggested that diabetes mellitus may predispose patients to
acquire liver abscess caused by K. pneumoniae;1,2 however, many
non-diabetic patients also develop this syndrome.2–4 Several
studies have also indicated that the capsular polysaccharide
(cps) K1 or K2 serotypes of K. pneumoniae aremostly responsible for
K. pneumoniae liver abscess.3,6 Recently, a novel virulent gene,
magA (mucoviscosity-associated gene A), has been identiﬁed in K.
pneumoniae isolates that have the cps K1 serotype.
7 This gene is* Corresponding author. Tel.: +886 7 7317123; fax: +886 7 7322402.
E-mail address: yangkd@cgmh.org.tw (K.-D. Yang).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2010.01.007related to the hypermucoviscosity (HV) phenotype, which exhibits
greater lethality in mice.7 Yu et al. reported that the presence of a
plasmid gene, rmpA (regulator of the mucoid phenotype A), was
correlated with abscess formation in patients with community-
acquired K. pneumoniae bacteremia.8 The rmpA gene in K.
pneumoniae is an independent risk factor for metastatic infection
in patients with K. pneumoniae liver abscess.9 The rmpA gene and/
or a related gene, rmpA2 (transcriptional activator), appear to
enhance extracapsular polysaccharide synthesis and thereby
confer the HV phenotype to K. pneumoniae.10 However, these
studies have been confounded by selection bias because they have
only examined K. pneumoniae strains isolated from patients with K.
pneumoniae liver abscess or community-acquired K. pneumoniae
bacteremia.
K. pneumoniae isolated from patients with distinctive invasive
syndrome are susceptible to most antibiotics and universally
resistant to ampicillin.1,2 Within a few years of the introduction of
cephalosporins, b-lactamase-producing K. pneumoniae strains
were commonly isolated from patients with nosocomial K.
pneumoniae infections. These b-lactamases were identiﬁed asses. Published by Elsevier Ltd. All rights reserved.
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which were initially restricted to the hospital environment, but
have recently spread to the community.11 Intriguingly, ESBL
production remains rare in strains of K. pneumoniae that are
responsible for distinctive invasive syndrome.12,13 It is crucial to
identify interactions between the virulent factors that inﬂuence
invasive syndrome and those that confer ESBL production to K.
pneumoniae.
The current study had two major objectives: (1) To deﬁne the
risk factors for K. pneumoniae-mediated distinctive invasive
syndrome by using a prospective cross-sectional study not
confounded by selection bias, and (2) to explore the relationship
between virulent factors of invasive syndrome and ESBL
production.
2. Materials and methods
2.1. Study design and deﬁnitions
This prospective cross-sectional study included all patients
with monomicrobial infection due to K. pneumoniae admitted to
the Chang Gung Memorial Hospital-Kaohsiung (CGMH-KS) be-
tween January 1 and March 31, 2008. CGMH-KS is a 2300-bed
facility that serves as a primary care and tertiary referral center in
southern Taiwan. Patients eligible for inclusion were identiﬁed
from the hospital’s microbiology laboratory, and were only
included after conﬁrmation of K. pneumoniae monomicrobial
infection following a review of their medical records. Demographic
and clinical data of the included patients were obtained from the
medical charts. A patient was included once if the cultures of
specimens sampled at different times all grew K. pneumoniae, and
in such circumstances, the ﬁrst episode and its K. pneumoniae
isolate were counted. This study was approved by the institutional
review board (No. 97-0599B), and the need for informed consent
was waived.
The diagnosis of invasive syndrome was made when a patient
had K. pneumoniae infection that fulﬁlled the criteria for sepsis14
in the presence of at least one of the following focal infections:
liver abscess, meningitis, empyema, mycotic aneurysm, and
endophthalmitis.3 Clinical variables including age, gender, and
underlying diseases (heavy alcohol consumption, diabetes
mellitus, liver cirrhosis, malignancy, chronic renal failure, and
biliary tract disease) were collected for analysis. Diabetes
mellitus was considered to be present if hemoglobin A1c was
7% with a random blood glucose level of 200 mg/dl or a
fasting blood glucose level of 126 mg/dl in repeated tests
during the hospital stay, or if the patient had a previous
diagnosis of diabetes mellitus.
2.2. Organism identiﬁcation, modiﬁed string test for
hypermucoviscosity, and ESBL detection
All K. pneumoniae isolates were identiﬁed by standard
methods15 and were screened for ESBLs according to Clinical
and Laboratory Standards Institute (CLSI) guidelines.16 The
potential ESBL producers were further tested and conﬁrmed using
a combined disk test.16 The HV phenotype of the K. pneumoniae
isolates was determined using a modiﬁed string test,2 in which a
standard bacteriological loop is used to stretch a mucoviscous
string from the bacterial colony. The formation of a viscous string
>10 mm in length was regarded as a positive test result.A total of
90 non-duplicated ESBL-producing K. pneumoniae isolates were
used for comparison. These isolates were obtained from patients
with nosocomial bacteremia who did not suffer from invasive
syndrome and were admitted to hospital from March 2004 to
February 2006.2.3. Detection of K serotype, magA, rmpA, and rmpA2 by polymerase
chain reaction
Previous studies have shown a complete agreement between
the K serotype and K genotype.6 The genomic DNA was extracted
from K. pneumoniae isolates to determine genotypes. With
genomic DNA as the template, PCR was performed with primer
pairs speciﬁc for the K. pneumoniae capsule gene cluster (cps K1, cps
K2)
6 and chromosome-mediated magA.8 Plasmid-mediated rmpA
was ampliﬁed by PCR with plasmid DNA as the template.8 The
rmpA2-speciﬁc primers were: forward, 5-CTTTATGTGCAATAAG-
GATGTT-3 and reverse, 5-CCTCCTGGAGAGTAAGCATT-3. Sequenc-
ing indicated that the target sequence had a high level of identity
(99%)with the published target sequence of the pLVPK plasmid of a
K. pneumoniae strain (GenBank accession number AY378100).17
Serotype K2 of K. pneumoniae ATCC 9997 was selected as the
positive control for cps K1 and cps K2 PCR.
1 The PCR product from
the ﬁrst strain tested was sequenced and showed a high level of
identity (>98%) with the published target sequence.6,8 This was
used as the positive control for subsequent PCR experiments. A
single, separate clinical isolate of Escherichia coli was used as the
negative control for all PCR experiments.
2.4. Statistical analysis
For statistical analysis, categorical variables were compared by
a Chi-square test or Fisher’s exact test, as appropriate. A
multivariate logistic regression model was used to evaluate risk
factors for distinctive invasive syndrome and ESBL production. A
binary logistic regression model was used to estimate the risk for
invasive syndrome relative to underlying disease with or without
diabetes mellitus in the presence of K. pneumoniae with HV
phenotype, cps K1/K2 serotype, or extracapsular polysaccharide
synthesis represented by positivity for the rmpA or rmpA2 gene.
Statistical signiﬁcance was deﬁned as p < 0.05 by two-tailed tests.
3. Results
3.1. Characteristics of K. pneumoniae isolates
A total of 91 patients with K. pneumoniae monobacterial
infections were identiﬁed. Among these, 19 patients (20.9%) had
distinctive invasive syndrome and 58 (63.7%) had community-
acquired infections. The most common underlying disease was
diabetes mellitus (n = 37, 40.7%), followed by malignancy (n = 16,
17.6%), chronic renal failure (n = 13, 14.3%), biliary tract diseases
(n = 8, 8.8%), heavy alcohol consumption (n = 7, 7.7%), and liver
cirrhosis (n = 6, 6.6%). Thirty-one patients had no underlying
diseaseswhen enrolled into this study. Among the sites of isolation
of K. pneumoniae in these 91 patients, themost commonwas blood
samples (n = 53, 58.2%). The other isolation sites included urine
samples (n = 18, 19.8%), wound or pus samples (n = 7, 7.7%),
sputum samples (n = 5, 5.5%), plural effusion samples (n = 4, 4.4%),
and ascites samples (n = 4, 4.4%).
Based on the results of the modiﬁed string test, HV phenotypes
were identiﬁed in 35 (38.5%) of the 91 isolates. The cps K1/K2 was
present in 15 isolates (16.5%), with K1 in eight (8.8%) and K2 in
seven (7.7%). Forty-two isolates were positive for the rmpA or
rmpA2 gene (46.2%), with rmpA found in 35 (38.5%) and rmpA2 in
41 (45.1%).magAwas shown to coexist with the cps K1 serotype in
eight (8.8%) isolates. The results of the combined disk test
indicated that 24 isolates (26.4%) were ESBL-producing strains.
One ESBL-producing K. pneumoniae strain expressed the HV
phenotype and ﬁve (20.8%) harbored rmpA or rmpA2. None of
these 24 ESBL-producing strains expressed cps K1/K2 or harbored
the magA gene.
Table 1
Association between the presence of rmpA, rmpA2, and magA genes and hypermucoviscosity phenotype in the 91 clinical Klebsiella pneumoniae isolates
Variable Hypermucoviscosity phenotype Positive expression rate
Positive (%) (n=35) Negative (%) (n=56)
rmpA negative/rmpA2 negative (n=49) 3 (8.6) 46 (82.1) 6.1%
rmpA positive/rmpA2 positive (n=34) 28 (80) 6 (10.7) 82.3%
rmpA positive/rmpA2 negative (n=1) 1 (2.9) 0 100%
rmpA negative/rmpA2 positive (n=7) 3 (8.6) 4 (7.1) 42.8%
rmpA positive or rmpA2 positive (n=42) 32 (91.4) 10 (17.9) 76.2%
magA positive/rmpA positive or rmpA2 positive (n=8) 7 (20) 1 (1.8) 87.5%
magA positive/rmpA negative/rmpA2 negative (n=0) 0 0 0
magA negative/rmpA positive or rmpA2 positive (n=34) 25 (71.4) 9 (16.1) 73.5%
magA negative/rmpA negative/rmpA2 negative (n=49) 3 (8.6) 46 (82.1) 6.1%
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The presence of a factor that enhances extracapsular polysac-
charide synthesis, rmpA or rmpA2, was found in 91.4% of the 35
isolates with the HV phenotype, while in only 17.9% of the 56
isolates without HV phenotype (Table 1). The coexistence ofmagA
and the rmpA or rmpA2 genes increased the frequency of
expression of the HV phenotype in the K. pneumoniae isolates
(76.2% to 87.5%); however, only seven (20%) isolates with the HV
phenotype were positive for both magA and rmpA or rmpA2.
Additionally, three (8.6%) isolates with the characteristic HV
phenotype were negative for magA, rmpA, and rmpA2. Overall, the
presence of rmpA or rmpA2, disregarding the presence ofmagA, was
signiﬁcantly associated with expression of the HV phenotype
compared with that of strains without these genes.Table 2
Risk factors for Klebsiella pneumoniae-mediated invasive syndrome
Variable Invasive s
Yes (%) (n
HV phenotype in K. pneumoniaea 18 (94.7)
ESBL production in K. pneumoniae 0
cps K1 or K2 in K. pneumoniae 9 (47.4)
Positive for rmpA or rmpA2 in K. pneumoniae 17 (89.5)
Positive for magA in K. pneumoniae 7 (36.8)
Male gender 10 (52.6)
Age 60 years 8 (42.1)
Heavy alcohol consumption 2 (10.5)
Diabetes mellitus 9 (47.4)
Liver cirrhosis 2 (10.5)
Malignancy 1 (5.3)
Chronic renal failure 4 (21.1)
Biliary tract diseases 2 (10.5)
Absence of underlying disease 7 (36.8)
HV, hypermucoviscosity; ESBL, extended-spectrum b-lactamase.
a Multivariate logistic regression analysis indicated that the HV phenotype
syndrome (OR 58.24; 95% CI 7.23–468.87; p < 0.001).
Table 3
Binary logistic regression analyses to estimate the risk of Klebsiella pneumoniae-mediated
positive for the rmpA/rmpA2 gene in K. pneumoniae strains and patients with or witho
Variable DM Invasive syndrome
Yes (%) (n=19)
HV phenotype No 9 (47.4)
Yes 9 (47.4)
cps K1 or K2 No 5 (26.3)
Yes 4 (21.1)
Positive for rmpA or rmpA2 gene No 8 (42.1)
Yes 9 (47.4)
HV, hypermucoviscosity; DM, diabetes mellitus; OR, odds ratio; CI, conﬁdence interval3.3. Risk factors for distinctive K. pneumoniae-mediated
invasive syndrome
Table 2 summarizes risk factors associated with distinctive
invasive syndrome. Univariate analysis indicated that distinctive
invasive syndrome mostly occurred in patients infected with K.
pneumoniae strains with the HV phenotype (p < 0.001), the cps K1/
K2 serotype (p < 0.001), positive for the rmpA or rmpA2 gene (p <
0.001), or positive for themagA gene (p < 0.001). Patients without
invasive syndrome were mostly infected by ESBL-producing K.
pneumoniae strains (p = 0.002).Multivariate analysis indicated that
infection by strains with the HV phenotype was an independent
risk factor for distinctive invasive syndrome (odds ratio (OR) 58.24,
95% conﬁdence interval (CI) 7.23–468.87; p < 0.001).
Binary logistic regression analysis, shown in Table 3, indicated
no signiﬁcant difference in invasive syndrome between patientsyndrome p-Value
=19) No (%) (n=72)
17 (23.6) <0.001
24 (33.3) 0.002
6 (8.3) <0.001
25 (34.7) <0.001
1 (1.4) <0.001
48 (66.7) 0.291
36 (50) 0.612
5 (6.9) 0.633
28 (38.9) 0.602
4 (5.6) 0.601
15 (20.8) 0.174
9 (12.5) 0.459
6 (8.3) 0.671
24 (33.3) 0.790
of K. pneumoniae was an independent risk factor for distinctive invasive
invasive syndrome due to the presence of the HV phenotype, cps K1/K2 serotype, or
ut diabetes mellitus
OR (95% CI) p-Value
No (%) (n=72)
12 (16.7) 1 (referent)
5 (6.9) 2.40 (0.59–9.67) 0.218
5 (6.9) 1 (referent)
1 (1.4) 4.00 (0.323–49.59) 0.280
18 (25) 1 (referent)
7 (9.7) 2.89 (0.79–10.53) 0.107
.
Table 4
Risk factors for infection by extended-spectrum b-lactamase-producing Klebsiella pneumoniae
Variable ESBL production p-Value
Yes (%) (n=24) No (%) (n=67)
HV phenotype in K. pneumoniaea 1 (4.2) 34 (50.7) <0.001
cps K1 or K2 in K. pneumoniae 0 15 (22.4) 0.009
Positive for rmpA or rmpA2 in K. pneumoniae 5 (20.8) 37 (55.2) 0.004
Positive for magA in K. pneumoniae 0 15 (22.4) 0.009
Male gender 12 (50) 46 (68.7) 0.138
Age 60 years 18 (75) 26 (38.8) 0.342
Heavy alcohol consumption 4 (16.7) 3 (4.5) 0.076
Diabetes mellitus 7 (29.2) 30 (44.8) 0.229
Liver cirrhosis 3 (12.5) 3 (4.5) 0.185
Malignancy 5 (20.8) 11 (16.4) 0.755
Chronic renal failure 6 (25) 7 (10.4) 0.097
Biliary tract diseases 4 (16.7) 4 (6.0) 0.200
Absence of underlying disease 6 (25) 25 (37.3) 0.324
ESBL, extended-spectrum b-lactamase; HV, hypermucoviscosity.
a Multivariate logistic regression analysis indicated that the HV phenotype in K. pneumoniaewas negatively associatedwith ESBL production (OR 0.042; 95%
CI 0.005–0.331; p=0.003).
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strains positive for the rmpA or rmpA2 gene, HV phenotype, or cps
K1/K2 serotype. These results suggest that the risk of K.
pneumoniae-mediated invasive syndrome among patients infected
by K. pneumoniae positive for the rmpA or rmpA2 gene, HV
phenotype, or cps K1/K2 serotype is not inﬂuenced by underlying
diabetes mellitus.
3.4. Factors associated with the ESBL
Table 4 summarizes the risk factors for ESBL production.
Univariate analysis indicated that the presence of ESBL production
was predominant in non-HV K. pneumoniae strains (p < 0.001), K.
pneumoniae strains with the absence of cps K1/K2 serotype
(p = 0.009), and the absence of rmpA or rmpA2 gene (p = 0.004).
Multiple logistic regression analysis indicated that non-HV K.
pneumoniaewas an independent predictor for the presence of ESBL
(OR 0.042, 95% CI 0.005–0.331; p = 0.003).
The 90 non-duplicate ESBL-producing K. pneumoniae isolates
from patients with nosocomial bacteremiawho did not suffer from
K. pneumoniae-mediated invasive syndrome were further tested
for the presence of the cps K1/K2 serotype and for the rmpA or
rmpA2 gene. All 90 isolates were non-HV and did not harbor the cps
K1/K2 serotype, but the rmpA or rmpA2 gene was found in 21 of
these strains. These results indicate a signiﬁcant negative
association between the HV phenotype and ESBL production in
these isolates.
4. Discussion
Previous reports have indicated that rmpA and magA are
responsible for abscess formation in 88.2% and 38.2% of cases of K.
pneumoniae community-acquired bacteremia8 and are also respon-
sible formetastatic infection in 87.5% and 50% of K. pneumoniae liver
abscess, respectively.9 Our results also demonstrate that strains
positive for rmpA/rmpA2 and magA were responsible for 89.5% and
36.8% of the occurrences of distinctive invasive syndrome, respec-
tively (Table2). The above three studies, all ofwhichwere conducted
in southern Taiwan, had similar frequencies of rmpA/rmpA2 and
magA. This is in contrast to other studies conducted in northern
Taiwan6,7 that showed the predominant virulent factor for K.
pneumoniae liver abscess and septic metastasis to be magA. This
suggests geographic differences in the distribution of K. pneumoniae
genotypes between northern and southern Taiwan.
When grown on culture plates, clinical isolates of K. pneumoniae
from invasive infections usually form glistening mucoid colonieswith viscid consistency. The pathogenic mechanisms of the HV
phenotype have been identiﬁed for various human pathogens.18–20
In general, HV phenotypes are more resistant to phagocytosis, less
sensitive to serum, and more virulent in animal studies.10,21–23
Which gene(s) are responsible for the HV phenotype are not yet
well known. The whole K1 capsular gene cluster (GenBank
accession number AY762939) and the magA gene are part of the
cps gene cluster of K. pneumoniae serotype K1.
24 The mucoidity
itself is distinct from capsular production.25 It explains the
signiﬁcant association of rmpA or rmpA2 with expression of the
HV phenotype. The rmpA and rmpA2 genes are regulators for the
synthesis of extracapsular polysaccharides, and it has been
suggested that these genes may be responsible for the HV
phenotype of K. pneumoniae;10 knockout experiments support
this proposal.22 In accordance with previous reports,8,9 the current
study demonstrates a signiﬁcant association between the rmpA/
rmpA2 gene and the HV phenotype (Table 1). However, 17.9% of K.
pneumoniae isolates with the rmpA or rmpA2 gene did not express
the HV phenotype. This result might be explained by negative
regulation via the Lon protease at the post-transcriptional level25
in the non-HV K. pneumoniae strains encoding the rmpA or rmpA2
gene. Nevertheless, Yu et al.26 reported that non-HV phenotype K.
pneumoniae isolates with the rmpA gene were less virulent to mice
(LD50 approximately 10
4 CFU) than HV phenotype isolates with
rmpA (LD50 approximately 10 CFU). Taken together, these results
suggest that there may be genetic elements other than exo-
lipopolysaccharide-associated genes (e.g.,magA, rmpA, and rmpA2)
or cps serotypes responsible for the HV phenotype and K.
pneumoniae-mediated invasive syndrome.
It is well known that plasmids can carry genes for antibiotic
resistance. K. pneumoniae, the most common species known to
carry plasmid-mediated ESBL genes, is a major cause of hospital-
acquired infections and is becoming a global problem in outpatient
settings.11 ESBL genes are rarely found in K. pneumoniae strains
with the HV phenotype and are responsible for invasive
syndrome.12,13 It is possible that other plasmid genes have a role
in the pathogenesis of invasive syndrome, and these might be
suppressed when the ESBL gene is present.27 This study found
ESBL-producing K. pneumoniae were all isolated from patients
without distinctive invasive syndrome, and nearly all these strains
had the non-HV phenotype. Thus, the rare occurrence of the HV
phenotype in ESBL-producing K. pneumoniae might elucidate the
reason as to why distinctive invasive infections are rarely caused
by ESBL-producing K. pneumoniae.
Despite diabetes mellitus being a common predisposing factor
for patients acquiring K. pneumoniae-mediated invasive syn-
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found in those patients from whom K. pneumoniae with cps K1/K2
were isolated.28 Therefore, in accordance with our binary logistic
regression analysis, given that such infections are also found in
previously healthy individuals, bacterial virulence must play a
major role in pathogenesis.7 This may partly explain how diabetes
mellitus might be a covariate factor rather than a determinant for
invasive syndrome caused by K. pneumoniae strains positive for the
rmpA or rmpA2 gene, HV phenotype, or cps K1/K2 serotype. In this
study, only eight patients were infectedwith K. pneumoniae strains
positive for magA and three had diabetes. Because of the small
sample size, this factor could not be evaluated as a risk factor in the
binary logistic regression model. Additional research is warranted
in order to establish the risk of distinctive invasive syndrome
among patients infected with K. pneumoniae positive for themagA
gene and with underlying diabetes mellitus.
5. Conclusions
Overall, our data suggest that a complex regulatory network
controls the expression of the HV phenotype of K. pneumoniae.
Patients with K. pneumoniae-mediated invasive syndrome are
more likely to be infected with an HV strain that lacks ESBL. The
role of the HV phenotype in K. pneumoniae-mediated distinctive
invasive syndrome deserves further study.
Conﬂict of interest
No conﬂict of interest to declare.
Acknowledgements
This study was supported in part by grant NSC 97-2314-B-
182A-028 from the National Science Council, Executive Yuan,
Taipei, Taiwan.
References
1. Lee CH, Leu HS, Wu TS, Su LH, Liu JW. Risk factors for spontaneous rupture of
liver abscess caused by Klebsiella pneumoniae. Diagn Microbiol Infect Dis
2005;52:79–84.
2. Lee HC, Chuang YC, YuWL, Lee NY, Chang CM, Ko NY, et al. Clinical implications
of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association
with invasive syndrome in patients with community-acquired bacteraemia. J
Intern Med 2006;259:606–14.
3. Yu VL, Hansen DS, Ko WC, Sagnimeni A, Klugman KP, von Gottberg A, et al.
Virulence characteristics of Klebsiella and clinical manifestations of K. pneu-
moniae bloodstream infections. Emerg Infect Dis 2007;13:986–93.
4. Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A, Mohapatra S,
et al. Community-acquired Klebsiella pneumoniae bacteremia: global differ-
ences in clinical patterns. Emerg Infect Dis 2002;8:160–6.
5. Rahimian J,Wilson T, OramV, HolzmanRS. Pyogenic liver abscess: recent trends
in etiology and mortality. Clin Infect Dis 2004;39:1654–9.
6. Fang CT, Lai SY, Yi WC, Hsueh PR, Liu KL, Chang SC. Klebsiella pneumoniae
genotype K1: an emerging pathogen that causes septic ocular or central nervous
system complications from pyogenic liver abscess. Clin Infect Dis 2007;45:284–
93.
7. Fang CT, Chuang YP, Shun CT, Chang SC, Wang JT. A novel virulence gene in
Klebsiella pneumoniae strains causing primary liver abscess and septic meta-
static complications. J Exp Med 2004;199:697–705.8. YuWL, KoWC, Cheng KC, Lee HC, Ke DS, Lee CC, et al. Association between rmpA
and magA genes and clinical syndromes caused by Klebsiella pneumoniae in
Taiwan. Clin Infect Dis 2006;42:1351–8.
9. Lee SS, Chen YS, Tsai HC,Wann SR, Lin HH, Huang CK, Liu YC. Predictors of septic
metastatic infection and mortality among patients with Klebsiella pneumoniae
liver abscess. Clin Infect Dis 2008;47:642–50.
10. Wacharotayankun R, Arakawa Y, Ohta M, Tanaka K, Akashi T, Mori M, Kato N.
Enhancement of extracapsular polysaccharide synthesis in Klebsiella pneumo-
niae by RmpA2, which shows homology to NtrC and FixJ. Infect Immun
1993;61:3164–74.
11. Pitout JD, Laupland KB. Extended-spectrum b-lactamase-producing Entero-
bacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008;8:
159–66.
12. Lin TL, Tang SI, Fang CT, Hsueh PR, Chang SC, Wang JT. Extended-spectrum b-
lactamase genes of Klebsiella pneumoniae strains in Taiwan: recharacterization
of shv-27, shv-41, and tem-116. Microb Drug Resist 2006;12:12–5.
13. Su SC, Siu LK, Ma L, Yeh KM, Fung CP, Lin JC, Chang FY. Community-acquired
liver abscess caused by serotype K1 Klebsiella pneumoniae with CTX-M-15-
type extended-spectrumb-lactamase. Antimicrob Agents Chemother 2008;52:
804–5.
14. American College of Chest Physicians/Society of Critical Care Medicine Con-
sensus Conference Committee. Deﬁnitions for sepsis and organ failure and
guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;
20:864–74.
15. Farmer III JJ. Enterobacteriaceae: introduction and identiﬁcation. In: Murray
PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical
microbiology. 8th ed., Washington, DC: ASM Press; 2003. p. 636–53.
16. Clinical and Laboratory Standards Institute. Performance standards for antimi-
crobial susceptibility testing. Document M100-S16. Villanova, PA: CLSI; 2006.
17. Chen YT, Chang HY, Lai YC, Pan CC, Tsai SF, Peng HL. Sequencing and analysis of
the large virulence plasmid pLVPK of Klebsiella pneumoniae CG43. Gene
2004;337:189–98.
18. Moses AE, Wessels MR, Zalcman K, Albertı´ S, Natanson-Yaron S, Menes T,
Hanski E. Relative contributions of hyaluronic acid capsule and M protein to
virulence in a mucoid strain of the group A Streptococcus. Infect Immun
1997;65:64–71.
19. Boucher JC, Yu H, Mudd MH, Deretic V. Mucoid Pseudomonas aeruginosa in
cystic ﬁbrosis: characterization of muc mutations in clinical isolates and
analysis of clearance in a mouse model of respiratory infection. Infect Immun
1997;65:3838–46.
20. Pietrella D, Fries B, Lupo P, Bistoni F, Casadevall A, Vecchiarelli A. Phenotypic
switching of Cryptococcus neoformans can inﬂuence the outcome of the human
immune response. Cell Microbiol 2003;5:513–22.
21. Nassif X, Fournier JM, Arondel J, Sansonetti PJ. Mucoid phenotype of Klebsiella
pneumoniae is a plasmid-encoded virulence factor. Infect Immun 1989;57:546–
52.
22. Vernet V, Philippon A, Madoulet C, Vistelle R, Jaussaud R, Chippaux C.
Virulence factors (aerobactin and mucoid phenotype) in Klebsiella pneumo-
niae and Escherichia coli blood culture isolates. FEMS Microbiol Lett
1995;130:51–7.
23. Arakawa Y, Wacharotayankun R, Nagatsuka T, Ito H, Kato N, Ohta M. Genomic
organization of the Klebsiella pneumoniae cps region responsible for serotype K2
capsular polysaccharide synthesis in the virulent strain Chedid. J Bacteriol
1995;177:1788–96.
24. Yeh KM, Chang FY, Fung CP, Lin JC, Siu LK.magA is not a speciﬁc virulence gene
for Klebsiella pneumoniae strains causing liver abscess but is part of the capsular
polysaccharide gene cluster of K. pneumoniae serotype K1. J Med Microbiol
2006;55:803–4.
25. Nassif X, Honore´ N, Vasselon T, Cole ST, Sansonetti PJ. Positive control of colanic
acid synthesis in Escherichia coli by rmpA and rmpB, two virulence-plasmid
genes of Klebsiella pneumoniae. Mol Microbiol 1989;3:1349–59.
26. Yu WL, Ko WC, Cheng KC, Lee CC, Lai CC, Chuang YC. Comparison of prevalence
of virulence factors for Klebsiella pneumoniae liver abscesses between isolates
with capsular K1/K2 and non-K1/K2 serotypes. Diagn Microbiol Infect Dis
2008;62:1–6.
27. Kawai T. Hypermucoviscosity: an extremely sticky phenotype of Klebsiella
pneumoniae associated with emerging destructive tissue abscess syndrome.
Clin Infect Dis 2006;42:1359–61.
28. Yu WL, Chan KS, Ko WC, Lee CC, Chuang YC. Lower prevalence of diabetes
mellitus in patients with Klebsiella pneumoniae primary liver abscess caused by
isolates of K1/K2 than with non-K1/K2 capsular serotypes. Clin Infect Dis
2007;45:1529–30.
